Development and characterization of exendin-4 loaded self-nanoemulsifying system and in vitro evaluation on Caco-2 cell line

References

• Ali, H., et al., 2008. Comparison between lipolysis and compendial dissolution as alternative techniques for the in vitro characterization of α-tocopherol self-emulsified drug delivery systems (SEDDS). International journal of pharmaceutics, 352 (1-2), 104–114.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2012. Diagnosis and classification of diabetes mellitus. Diabetes care, 35, 64–71.
   PubMed Web of Science ®Google Scholar
• Balakrishnan, P., et al., 2009. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. International journal of pharmaceutics, 374 (1-2), 66–72.
   PubMed Web of Science ®Google Scholar
• Bhansali, A., et al., 2010. Historical overview of incretin-based therapies. Supplement to japi, 58, 10–13.
   Google Scholar
• Celik-Tekeli, M., Celebi, N., and Aktas, Y., 2018. Development and characterization of self nanoemulsifiying formulation for oral peptide delivery. In:12th International Symposium on Pharmaceutical Sciences (ISOPS), 26–29 June 2018. Ankara, Turkey. (http://www.isops-ankara.org/ISOPS12-AbstractBook.pdf), 310.
   Google Scholar
• Chen, M.C., et al., 2013. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules. Advanced drug delivery reviews, 65 (6), 865–879.
   PubMed Web of Science ®Google Scholar
• Christophersen, P.C., et al., 2014. Fed and fasted state gastro-intestinal in vitro lipolysis: in vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS. European journal of pharmaceutical sciences, 57, 232–239.
   PubMed Web of Science ®Google Scholar
• Chuang, E.Y., et al., 2013. Combination therapy via oral co-administration of insulin and exendin-4 loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT. Biomaterials, 34 (32), 7994–8001.
   PubMed Web of Science ®Google Scholar
• Gupta, V., Doshi, N., and Mitragotri, S., 2013. Permeation of insulin, calcitonin and exenatide across Caco-2 monolayers: measurement using a rapid, 3-day system. PLoS one, 8 (2), e57136.
   PubMed Web of Science ®Google Scholar
• Gursoy, R.N., and Benita, S., 2004. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine & pharmacotherapy, 58, 173–182.
   PubMed Web of Science ®Google Scholar
• Hintzen, F., et al., 2014. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin. International journal of pharmaceutics, 472 (1-2), 20–26.
   PubMed Web of Science ®Google Scholar
• Ismail, R., and Csóka, I., 2017. Novel strategies in the oral delivery of antidiabetic peptide drugs –insulin, GLP 1 and its analogs. European journal of pharmaceutics and biopharmaceutics, 115, 257–267.
   PubMed Web of Science ®Google Scholar
• Kumar, A., Sharma, S., and Kamble, R., 2010. Self-emulsifying drug delivery system (SEDDS): future aspects. International journal of pharmacy and pharmaceutical sciences, 2, 7–13.
   Google Scholar
• Leonaviciute, G., et al., 2017. Self-emulsifying drug delivery systems (SEDDS): proof-of-concept how to make them mucoadhesive. European journal of pharmaceutics and biopharmaceutics, 112, 51–57.
   PubMed Web of Science ®Google Scholar
• Leonaviciute, G., and Bernkop-Schnurch, A., 2015. Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery. Expert opinion on drug delivery, 12 (11), 1703–1716.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2015. The glucose-lowering potential of exenatide delivered orally via goblet cell-targeting nanoparticles. Pharmaceutical research, 32 (3), 1017–1027.
   PubMed Web of Science ®Google Scholar
• Oh, K.S., et al., 2014. Sol-gel transition of nanoparticles/polymer mixtures for sustained delivery of exenatide to treat type 2 diabetes mellitus. European journal of pharmaceutics and biopharmaceutics, 88 (3), 664–669.
   PubMed Web of Science ®Google Scholar
• Park, K., Kwon, C.I., and Park, K., 2011. Oral protein delivery: current status and future prospect. Reactive and functional polymers, 71 (3), 280–287.
   Web of Science ®Google Scholar
• Renukuntla, J., et al., 2013. Approaches for enhancing oral bioavailability of peptides and proteins. International journal of pharmaceutics, 447 (1-2), 75–93.
   PubMed Web of Science ®Google Scholar
• Sakloetsakun, D., et al., 2013. Combining two technologies: multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration. International journal of biological macromolecules, 61, 363–372.
   PubMed Web of Science ®Google Scholar
• Salvia-Trujillo, L., Martín-Belloso, O., and McClements, D.J., 2016. Excipient nanoemulsions for ımproving oral bioavailability of bioactives. Nanomaterials, 6 (1), 17.
   Web of Science ®Google Scholar
• Sha, X., et al., 2005. Effect of self-microemulsifying drug delivery systems containing labrasol on tight junctions in Caco-2 cells. European journal of pharmaceutical sciences, 24 (5), 477–486.
   PubMed Web of Science ®Google Scholar
• Shahba, A.A.W., Mohsin, K., and Alanazi, F.K., 2012. Novel self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of cinnarizine: design, optimization, and in vitro assessment. AAPS pharmscitech, 13 (3), 967–977.
   PubMed Web of Science ®Google Scholar
• Soudry-Kochavi, L., et al., 2015. Improved oral absorption of exenatide using an original nanoencapsulation and microencapsulation approach. Journal of controlled release, 217, 202–210.
   PubMed Web of Science ®Google Scholar
• Sun, Y., et al., 2016. An investigation into the gastrointestinal stability of exenatide in the presence of pure enzymes, everted intestinal rings and intestinal homogenates. Biological and pharmaceutical bulletin, 39, 42–48.
   PubMed Web of Science ®Google Scholar
• Tan, M.L., Choong, P.F., and Dass, C.R., 2010. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides, 31 (1), 184–193.
   PubMed Web of Science ®Google Scholar
• Thomas, N., et al., 2012. Characterising lipid lipolysis and its implication in lipid-based formulation development. The aaps journal, 14 (4), 860–871.
   PubMed Web of Science ®Google Scholar
• Wang, M., et al., 2013. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co glycolide) nanoparticles for intestinal delivery of exendin-4. International journal of pharmaceutics, 8, 1141–1154.
   Google Scholar
• Zupančič, O., et al., 2016. Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration. European journal of pharmaceutics and biopharmaceutics, 109, 113–121.
   PubMed Web of Science ®Google Scholar